| P50 | author | Qingzhong Yu | Q64005569 |
| P2093 | author name string | Haixia Hu | |
| | Jason P Roth | |
| P2860 | cites work | Evaluating viral interference between infectious bronchitis virus and Newcastle disease virus vaccine strains using quantitative reverse transcription-polymerase chain reaction | Q45397355 |
| | Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone. | Q45400966 |
| | Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication | Q45728622 |
| | Recombinant Newcastle disease virus as a vaccine vector. | Q53654257 |
| | Recombinant Newcastle disease virus as a vaccine vector for cancer therapy | Q24602728 |
| | Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines | Q26744220 |
| | Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. | Q30382650 |
| | Engineered Newcastle disease virus expressing the F and G proteins of AMPV-C confers protection against challenges in turkeys. | Q33826199 |
| | Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy | Q34028464 |
| | Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges. | Q34057946 |
| | Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice | Q34059360 |
| | Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression | Q34343430 |
| | Taxonomy of the order Mononegavirales: update 2017. | Q34554971 |
| | Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus | Q34680077 |
| | Avian influenza and Newcastle disease | Q35144536 |
| | Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges | Q35883750 |
| | The nature and consequences of intra- and inter-vaccine interference | Q36846055 |
| | A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. | Q37492711 |
| | Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer | Q37535829 |
| | Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies. | Q38406055 |
| | Genetically engineered Newcastle disease virus expressing human interferon-λ1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response | Q38757381 |
| | Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy. | Q38771391 |
| | Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model | Q39013995 |
| | Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs | Q39326613 |
| | Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy. | Q40314258 |
| | Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation | Q40735127 |
| | Genome replication of Newcastle disease virus: involvement of the rule-of-six | Q40847135 |
| | Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes | Q40870853 |
| | Multivalent vaccines: prospects and challenges | Q40911430 |
| | Development of a Newcastle disease virus vector expressing a foreign gene through an internal ribosomal entry site provides direct proof for a sequential transcription mechanism | Q41335524 |
| | P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression. | Q41719384 |
| | Infectious Bronchitis Virus S2 of 4/91 Expressed from Recombinant Virus Does Not Protect Against Ark-Type Challenge | Q41928736 |
| | Recombinant Newcastle disease viral vector expressing hemagglutinin or fusion of canine distemper virus is safe and immunogenic in minks | Q42149271 |
| | A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens | Q42216746 |
| | Infectious bronchitis virus S2 expressed from recombinant virus confers broad protection against challenge | Q42218211 |
| | Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus | Q43175719 |
| | Generation of recombinant lentogenic Newcastle disease virus from cDNA. | Q43647240 |
| | Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens | Q45362258 |
| | Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. | Q45363233 |
| | Efficacy of Newcastle disease virus recombinant expressing avian influenza virus H6 hemagglutinin against Newcastle disease and low pathogenic avian influenza in chickens and turkeys | Q45364663 |
| P433 | issue | 32 Pt B | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Newcastle disease | Q11903425 |
| | Newcastle disease virus | Q327082 |
| P304 | page(s) | 4846-4850 | |
| P577 | publication date | 2018-06-30 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Generation of a recombinant Newcastle disease virus expressing two foreign genes for use as a multivalent vaccine and gene therapy vector | |
| P478 | volume | 36 | |